BE726570A - - Google Patents
Info
- Publication number
- BE726570A BE726570A BE726570DA BE726570A BE 726570 A BE726570 A BE 726570A BE 726570D A BE726570D A BE 726570DA BE 726570 A BE726570 A BE 726570A
- Authority
- BE
- Belgium
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH35068 | 1968-01-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE726570A true BE726570A (en:Method) | 1969-07-07 |
Family
ID=4185009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE726570D BE726570A (en:Method) | 1968-01-09 | 1969-01-07 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3557287A (en:Method) |
| AT (1) | AT305491B (en:Method) |
| BE (1) | BE726570A (en:Method) |
| BR (1) | BR6905370D0 (en:Method) |
| CA (1) | CA921402A (en:Method) |
| DE (1) | DE1900307A1 (en:Method) |
| FR (1) | FR8187M (en:Method) |
| GB (1) | GB1247801A (en:Method) |
| IE (1) | IE32612B1 (en:Method) |
| IL (1) | IL31384A (en:Method) |
| NL (1) | NL6818027A (en:Method) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4165376A (en) * | 1971-01-29 | 1979-08-21 | Lake Shore Roentgenology, Ltd. | Treatment of the acute after-effects resulting from alcohol ingestion |
| US5069911A (en) * | 1985-02-05 | 1991-12-03 | Sandoz Ltd. | Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions |
| US7060711B2 (en) * | 2001-10-25 | 2006-06-13 | Biofrontera Bioscience Gmbh | Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist |
| EP1306376A1 (en) * | 2001-10-25 | 2003-05-02 | Biofrontera Pharmaceuticals AG | Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist |
| AU2004253898A1 (en) | 2003-06-27 | 2005-01-13 | Janssen Pharmaceutica N.V. | Tricyclic delta opioid modulators |
| JP2008529971A (ja) * | 2004-08-05 | 2008-08-07 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 三環式δ−オピオイド調節剤 |
| EP1655027A1 (en) * | 2004-11-04 | 2006-05-10 | Biofrontera Pharmaceuticals GmbH | 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension and migraine |
| EP1833825A1 (en) * | 2004-12-22 | 2007-09-19 | Janssen Pharmaceutica N.V. | Tricyclic delta-opioid modulators |
| AU2005319059A1 (en) * | 2004-12-22 | 2006-06-29 | Janssen Pharmaceutica N.V. | Tricyclic delta-opioid modulators |
| US7439239B2 (en) * | 2004-12-22 | 2008-10-21 | Janssen Pharmaceutica N.V. | Tricyclic δ- opioid modulators |
| KR20070104380A (ko) * | 2005-01-06 | 2007-10-25 | 얀센 파마슈티카 엔.브이. | 트리사이클릭 δ-오피오이드 조절제 |
| EP1896467B1 (en) * | 2005-06-16 | 2010-12-01 | Janssen Pharmaceutica NV | Tricyclic opioid modulators |
| WO2014117863A1 (en) | 2013-02-01 | 2014-08-07 | Biofrontera Bioscience Gmbh | Salt polymorph of thioxanthene - 9 - ylidene - 1 - methyl piperidine acid addition salts as antimigraine compounds |
-
1968
- 1968-12-16 NL NL6818027A patent/NL6818027A/xx unknown
- 1968-12-23 FR FR179962A patent/FR8187M/fr not_active Expired
- 1968-12-31 US US788351A patent/US3557287A/en not_active Expired - Lifetime
-
1969
- 1969-01-03 DE DE19691900307 patent/DE1900307A1/de active Pending
- 1969-01-07 CA CA039427A patent/CA921402A/en not_active Expired
- 1969-01-07 AT AT9769A patent/AT305491B/de not_active IP Right Cessation
- 1969-01-07 IE IE27/69A patent/IE32612B1/xx unknown
- 1969-01-07 BE BE726570D patent/BE726570A/xx unknown
- 1969-01-07 BR BR205370/69A patent/BR6905370D0/pt unknown
- 1969-01-08 IL IL31384A patent/IL31384A/en unknown
- 1969-01-08 GB GB0220/69A patent/GB1247801A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA921402A (en) | 1973-02-20 |
| DE1900307A1 (de) | 1969-09-04 |
| AT305491B (de) | 1973-02-26 |
| BR6905370D0 (pt) | 1973-02-08 |
| IL31384A (en) | 1972-10-29 |
| US3557287A (en) | 1971-01-19 |
| NL6818027A (en:Method) | 1969-07-11 |
| FR8187M (en:Method) | 1970-09-07 |
| GB1247801A (en) | 1971-09-29 |
| IE32612B1 (en) | 1973-10-03 |
| IL31384A0 (en) | 1969-03-27 |
| IE32612L (en) | 1969-07-09 |